Minerva Neurosciences (NERV) Misses Q1 EPS by 4c

Minerva Neurosciences (NASDAQ: NERV) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Wells Fargo previews Q2 midstream earnings, favors PAA and TRGP
• Nasdaq president says SK Hynix blockbuster IPO to draw foreign firms to US